In a healthy brain, there are over 100 billion nerve cells connected to extensions. With the onset of Alzheimer’s disease, information transfer at the synapses (the connection between the nerve cells and extensions) starts to break down, and the number of synapses decreases significantly. This results in the following symptoms characteristic of Alzheimer’s:
Every 70 seconds, someone in America develops Alzheimer’s disease. While the cause is still unknown, most experts agree that is isn’t caused by a single factor, but rather multiple factors. However, one common factor is advancing age. An estimated 5.3 million Americans have Alzheimer’s disease, with nearly 97% of those over the age of 65.
Today, new treatments and advances in research are giving new hope to people affected by this disease. The Alzheimer’s Stem Cell Clinical Trials are being studied for their efficacy in improving the complications in patients with Alzheimer’s, through the use of stem cells. These procedures may help patients who don't respond to typical drug treatment.
To learn more about StemGenex clinical trials for Alzheimer’s simply fill out the form below and a StemGenex Patient Advocate will contact you shortly.
Fields marked with an asterisk (*) are required.
Question IDs
Object Type Map
Visibility Map
Active Map
Validator Map
Children Map
Parent Map
Question Options Map
Question Options
Question Option Activate Map